These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 16930903)

  • 1. C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease.
    Link CD
    Exp Gerontol; 2006 Oct; 41(10):1007-13. PubMed ID: 16930903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invertebrate models of Alzheimer's disease.
    Link CD
    Genes Brain Behav; 2005 Apr; 4(3):147-56. PubMed ID: 15810903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
    Rockenstein E; Crews L; Masliah E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proteins and mutations: a new vision (molecular) of neurodegenerative diseases].
    Christen Y
    J Soc Biol; 2002; 196(1):85-94. PubMed ID: 12134639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Animal models of neurodegenerative diseases].
    Langui D; Lachapelle F; Duyckaerts C
    Med Sci (Paris); 2007 Feb; 23(2):180-6. PubMed ID: 17291428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of amyloid-beta-related pathologies in Alzheimer's disease.
    Philipson O; Lord A; Gumucio A; O'Callaghan P; Lannfelt L; Nilsson LN
    FEBS J; 2010 Mar; 277(6):1389-409. PubMed ID: 20136653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caenorhabditis elegans: a useful tool to decipher neurodegenerative pathways.
    Johnson JR; Jenn RC; Barclay JW; Burgoyne RD; Morgan A
    Biochem Soc Trans; 2010 Apr; 38(2):559-63. PubMed ID: 20298221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic targets from a Drosophila model of Alzheimer's disease.
    Crowther DC; Kinghorn KJ; Page R; Lomas DA
    Curr Opin Pharmacol; 2004 Oct; 4(5):513-6. PubMed ID: 15351357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans.
    Wang C; Saar V; Leung KL; Chen L; Wong G
    Neurobiol Dis; 2018 Jan; 109(Pt A):88-101. PubMed ID: 28982592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans.
    Kraemer BC; Burgess JK; Chen JH; Thomas JH; Schellenberg GD
    Hum Mol Genet; 2006 May; 15(9):1483-96. PubMed ID: 16600994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drosophila models of human neurodegenerative disease.
    Chan HY; Bonini NM
    Cell Death Differ; 2000 Nov; 7(11):1075-80. PubMed ID: 11139281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Abeta(1-42): implications for Alzheimer's disease.
    Boyd-Kimball D; Poon HF; Lynn BC; Cai J; Pierce WM; Klein JB; Ferguson J; Link CD; Butterfield DA
    Neurobiol Aging; 2006 Sep; 27(9):1239-49. PubMed ID: 16099075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals.
    Smith IF; Green KN; LaFerla FM
    Cell Calcium; 2005; 38(3-4):427-37. PubMed ID: 16125228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The model Caenorhabditis elegans in diabetes mellitus and Alzheimer's disease.
    Morcos M; Hutter H
    J Alzheimers Dis; 2009; 16(4):897-908. PubMed ID: 19387121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegenerative conditions associated with ageing: a molecular interplay?
    Troulinaki K; Tavernarakis N
    Mech Ageing Dev; 2005 Jan; 126(1):23-33. PubMed ID: 15610759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caenorhabditis elegans as a model system for Parkinson's disease.
    Schmidt E; Seifert M; Baumeister R
    Neurodegener Dis; 2007; 4(2-3):199-217. PubMed ID: 17596715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nematode Caenorhabditis elegans: a versatile model for the study of proteotoxicity and aging.
    Volovik Y; Marques FC; Cohen E
    Methods; 2014 Aug; 68(3):458-64. PubMed ID: 24794346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes.
    David DC; Ittner LM; Gehrig P; Nergenau D; Shepherd C; Halliday G; Götz J
    Proteomics; 2006 Dec; 6(24):6566-77. PubMed ID: 17111439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.